Before the Letter Arrives: A Capital Allocation Doctrine for UK Boards in an Activist Year

For a UK plc board, the activist letter is seldom the beginning of the argument. It is the moment the argument becomes public. By then, the challenge to a buyback programme, a dividend policy or a persistently unproductive capital project has usually been running for months in private meetings with shareholders, in sell-side notes and in the analysts' questions at the interim results.

The boards that withstand that scrutiny best are rarely the most combative. They are the ones able to point to a capital allocation doctrine agreed in quieter conditions, applied consistently and evidenced with numbers rather than adjectives. In what looks set to be another active year for UK shareholder engagement, having that doctrine on file before the letter arrives is the practical distinction that matters.

Why preparation pays in 2026

UK equity valuations remain undemanding relative to many developed markets. That is precisely the condition that invites activism: inexpensive equity, cash-generative balance sheets and shareholders impatient for a re-rating. The past two years have produced prominent campaigns across the large-cap index, in energy, engineering and mining among other sectors, and the pressure has filtered steadily down the market capitalisation scale.

The reporting framework has tightened in parallel. The 2024 UK Corporate Governance Code applies to accounting periods beginning on or after 1 January 2025, which means many companies are setting out their first declarations under the internal controls provision in 2026. The expectations placed on a board to describe how it stewards capital — and how it knows that stewardship is working — have risen accordingly.

Three claims on the same balance sheet

Every board allocates between reinvestment, distributions and balance sheet strength. A doctrine should state, in advance, the hierarchy and the evidence required to move between the tiers. It should also state the conditions under which the hierarchy changes, because the criticism that most damages credibility is inconsistency dressed as flexibility.

The doctrine need not be long. It does need to be specific enough that a shareholder can test it and a board can be held to it.

Buybacks are a price decision, not a sentiment

Buybacks remain the most contested instrument. In the UK they operate inside a settled legal architecture: shareholder authority under the Companies Act 2006, customary limits of around ten per cent of issued share capital under the Pre-emption Group's principles, listing rule requirements for premium-listed issuers, and the market abuse regime's conditions for execution within a safe harbour. None of that tells a board whether repurchasing its own shares at a particular price creates value.

The test should be written down. A buyback improves value for remaining holders where the return on the capital repurchased exceeds the company's cost of capital at the prevailing price, and where no higher-returning internal use of that capital is available on a comparable risk basis. That requires a view of intrinsic value, formed independently of the share price chart, and reviewed as the price moves.

A board should therefore be able to say what it thinks the business is worth, on what assumptions, and at what price the buyback stops being accretive. A programme authorised to a fixed percentage of capital with no price discipline is a signal of resignation rather than conviction.

Dividends are a commitment, not a variable

Distributable profits under the Companies Act, cash cover and the cyclicality of the underlying business set the boundary within which dividend policy operates. Within that boundary, the choice is between a progressive policy and a payout ratio, and each carries a different promise to shareholders.

A progressive policy commits the board to a direction of travel and makes a cut expensive in credibility. A payout ratio preserves flexibility but invites the annual argument. Whichever is adopted, the doctrine should specify the cover range the board regards as appropriate through the cycle and the circumstances in which it would depart from it. A board that has pre-committed to a cover range has a defensible answer when earnings fall; one that has not is left improvising under scrutiny.

Reinvestment is the hardest case to argue

Reinvestment is where activists land most effectively, because it rests on forecasts rather than on facts. The remedy is disclosure of the track record: hurdle rates by business unit, return on invested capital against cost of capital, and post-completion reviews of significant capital projects. Where returns have disappointed, say so and explain what changed.

Boards are often reluctant to publish such material for fear of handing ammunition to critics. In practice the reverse is true. A board that has already identified its underperforming capital and set out a remedy occupies the ground an activist would otherwise take. The company that publishes nothing invites the campaigner to write the narrative.

Four tests worth applying

A workable doctrine rests on four questions. Is there evidence for the decision, and is that evidence available to shareholders? Is the horizon consistent with the company's obligations and with its stated strategy? Is the decision reversible, and at what cost if it proves wrong? And is it disclosed clearly enough that a reasonable investor can follow the reasoning?

A decision that fails all four is unlikely to survive a public campaign. A decision that passes all four can be defended on its merits, whatever the share price does in the following quarter.

When strength means holding the position

There are moments when the appropriate response to a well-argued demand is a reasoned refusal. A board that believes its reinvestment programme will generate superior returns should say so, publish the milestones by which it expects to be judged, and accept the accountability that follows.

Refusal without a timetable reads as entrenchment. A timetable without a credible alternative reads as delay. The discipline lies in pairing the two: a specific commitment, a named measure and a date on which the board will report against it.

Equally, boards should recognise the opposite failure. Conceding to a demand the board does not believe in tends to produce a second demand within twelve months, because it demonstrates that pressure works and that the doctrine was negotiable. The cost of an early concession is rarely confined to the decision itself.

Legibility as a defence

A capital allocation doctrine is not a shield against criticism, and it should not be presented as one. It is a means of making the board's reasoning legible to the people who own the company. That legibility is the board's strongest practical asset in an activist year — not because it guarantees agreement, but because it moves the argument from assertion to evidence, where a well-run company is generally on firmer ground.